Bispecific antibodies to IL-23 and IL-17A/F
US8945553B2 · kind B2 · utility
8Cited by
31References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2013 |
| Grant date | Feb 3, 2015 |
| Priority date | — |
| Expiry date | May 21, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antagonizing the activity of IL-17A, IL-17F and IL-23 using bispecific antibodies that comprise a binding entity that is cross-reactive for IL-17A and IL-17F and a binding entity that binds IL-23p19. The present invention relates to novel bispecific antibody formats and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.